Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of a 36 Gy elective node irradiation dose in anal cancer.
Lépinoy A, Lescut N, Puyraveau M, Caubet M, Boustani J, Lakkis Z, Fantoli M, Buffet-Miny J, Kim S, Bednarek C, Maingon P, Créhange G, Bosset JF. Lépinoy A, et al. Among authors: bosset jf. Radiother Oncol. 2015 Aug;116(2):197-201. doi: 10.1016/j.radonc.2015.07.050. Epub 2015 Aug 12. Radiother Oncol. 2015. PMID: 26277433
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.
Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouché O, Bosset JF, Aparicio T, Mineur L, Azzedine A, Hammel P, Butel J, Stremsdoerfer N, Maingon P, Bedenne L. Chauffert B, et al. Among authors: bosset jf. Ann Oncol. 2008 Sep;19(9):1592-9. doi: 10.1093/annonc/mdn281. Epub 2008 May 7. Ann Oncol. 2008. PMID: 18467316 Free article. Clinical Trial.
Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups.
Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, Van der Steen-Banasik E, Trivière N, Stüben G, Puyraveau M, Mercier M; European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Bosset JF, et al. Eur J Cancer. 2003 Jan;39(1):45-51. doi: 10.1016/s0959-8049(02)00377-5. Eur J Cancer. 2003. PMID: 12504657 Free article. Clinical Trial.
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.
Borg C, André T, Mantion G, Boudghène F, Mornex F, Maingon P, Adenis A, Azria D, Piutti M, Morsli O, Bosset JF. Borg C, et al. Among authors: bosset jf. Ann Oncol. 2014 Nov;25(11):2205-2210. doi: 10.1093/annonc/mdu377. Epub 2014 Aug 13. Ann Oncol. 2014. PMID: 25122693 Free article. Clinical Trial.
[Cancer of the rectum: target volumes for preoperative radiotherapy].
Lorchel F, Maingon P, Crehange G, Bosset M, Bosset JF. Lorchel F, et al. Among authors: bosset m, bosset jf. Cancer Radiother. 2002 Nov;6 Suppl 1:93s-99s. doi: 10.1016/s1278-3218(02)00231-7. Cancer Radiother. 2002. PMID: 12587387 Review. French.
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group.
Bosset JF, Horiot JC, Hamers HP, Cionini L, Bartelink H, Caspers R, Untereiner M, Ciambelloti E, Pierart M, Van Glabbeke M. Bosset JF, et al. Radiother Oncol. 2001 Oct;61(1):7-13. doi: 10.1016/s0167-8140(01)00419-4. Radiother Oncol. 2001. PMID: 11578723 Clinical Trial.
184 results